-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Depreciation history and growth rate from 2022 to Q3 2025.
- Vir Biotechnology, Inc. Depreciation for the quarter ending September 30, 2025 was $2.9M, unchanged year-over-year.
- Vir Biotechnology, Inc. Depreciation for the twelve months ending September 30, 2025 was $11.3M, a 28.5% decline year-over-year.
- Vir Biotechnology, Inc. annual Depreciation for 2024 was $14.2M, a 24.9% decline from 2023.
- Vir Biotechnology, Inc. annual Depreciation for 2023 was $18.9M, a 200% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)